Form 4: Director Leslie Stone Heisz Receives EW Stock Grant

Edwards Lifesciences Director Leslie Stone Heisz was granted 3,251 restricted stock units as part of the company's nonemployee director incentive program.

Summary

• Director Leslie Stone Heisz acquired 3,251 restricted stock units (RSUs) of Edwards Lifesciences Corp (EW) on May 8, 2026.
• The shares were granted at a price of $0.00 per share under the 2020 Nonemployee Directors Stock Incentive Program.
• Following this transaction, the director's total beneficial ownership of common stock increased to 34,199 shares.
• The RSUs are scheduled to vest fully after one year or at the next annual meeting of stockholders, whichever occurs first.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standardized incentive program usage indicates stable corporate governance practices.

Negatives

• None identified; this is a routine compensatory filing.

Risks

• None identified; this is a routine compensatory filing.

Future Outlook

The RSUs are set to vest in one year or upon the next annual meeting of stockholders, aligning the director's long-term interests with the company's performance.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard industry practice in the medical device sector to ensure board members maintain a vested interest in long-term corporate performance.

Comparison to Industry Standards

• The grant follows standard corporate governance practices for S&P 500 companies.
• The vesting schedule is consistent with typical director compensation packages in the healthcare technology industry.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensatory equity grant.

Next Steps

• Vesting of the 3,251 restricted stock units in May 2027 or at the next annual meeting.

Key Dates

Keywords

Edwards Lifesciences, EW, Form 4, Insider Trading, Director Compensation, Restricted Stock Units